Two new [asperxins A (1) and B (2)] and four known (3-6) aflatoxins were isolated and identified from the endophytic fungus Aspergillus sp. Y-2, which was derived from the needles of the critically endangered conifer Abies beshanzuensis. Their structures were elucidated by extensive spectroscopic methods. Among the isolates, compounds 1 and 5 showed considerable cytotoxicities against the A549 and Hela human cancer cell lines, with IC 50 values in the range of 7.5-16.8 μM.
Antimicrobial photodynamic therapy
(aPDT) has emerged as a novel
and promising approach for the treatment of pathogenic microorganism
infections. The efficacy of aPDT depends greatly on the behavior of
the photosensitizer. Herein, we report the design, preparation, antimicrobial
photodynamic activities, as well as structure–activity relationships
of a series of photosensitizers modified at the meso position of a 1,3,5,7-tetramethyl BODIPY scaffold with various pyridinyl
and pyridinium moieties. The photodynamic antimicrobial activities
of all photosensitizers have been tested against Staphylococcus
aureus, Escherichia coli, Candida albicans, and Methicillin-resistant S. aureus (MRSA). The methyl meso-(meta-pyridinium) BODIPY photosensitizer (3c) possessed the highest phototoxicity against these pathogens
at minimal inhibitory concentrations (MIC) ranging from 0.63 to 1.25
μM with a light dose of 81 J/cm2. Furthermore, 3c exhibited an impressive antimicrobial efficacy in S. aureus-infected mice wounds. Taken together, these
findings suggest that 3c is a promising candidate as
the antimicrobial photosensitizer for combating pathogenic microorganism
infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.